Should endoscopic stenting be the initial treatment of malignant biliary obstruction?
- PMID: 1384416
- PMCID: PMC2497636
Should endoscopic stenting be the initial treatment of malignant biliary obstruction?
Abstract
Forty-two patients with biliary obstruction caused by a stricture had a diagnostic ERCP with subsequent insertion of a straight 10G endoprosthesis. These patients represented 70% of a cohort in which stent insertion had been attempted. The majority (63%) had pancreatic carcinoma, but 22% had malignant hilar obstruction. Five patients (12%) died within a few days of stent insertion; ERCP may have contributed to two deaths. Jaundice was relieved in all survivors. Median hospital stay was 6 days (range 2-32 days). After further investigation, nine patients were thought to be potentially curable and underwent laparotomy. Late complications after stent insertion alone included cholangitis (26%) and recurrent jaundice (28%). Only one patient developed gastric outlet obstruction and needed a gastroenterostomy. Median survival in the endoprosthesis group was 11 weeks (range 2-84 weeks). Survival was longer for patients with bile duct (14 weeks) rather than hilar strictures (6 weeks). Median survival after subsequent surgery was 40 weeks (range 4-80 weeks) with two long-term survivors. This study confirms that ERCP and stent insertion is a useful initial treatment for obstructive jaundice due to a biliary stricture, being both diagnostic and therapeutic. Subsequent evaluation for curative surgery is not precluded and in the majority of cases worthwhile palliation may be achieved by stenting alone.
Comment in
-
Should endoscopic stenting be the initial treatment of malignant biliary obstruction?Ann R Coll Surg Engl. 1993 Mar;75(2):140. Ann R Coll Surg Engl. 1993. PMID: 7682797 Free PMC article. No abstract available.
Similar articles
-
Clinical outcome of simultaneous self-expandable metal stents for palliation of malignant biliary and duodenal obstruction.Surg Endosc. 2003 Mar;17(3):457-61. doi: 10.1007/s00464-002-8541-3. Epub 2002 Oct 31. Surg Endosc. 2003. PMID: 12404053
-
Effectiveness of combined biliary and duodenal stenting in patients with malignant biliary and duodenal obstruction.Scand J Gastroenterol. 2012 Sep;47(8-9):962-7. doi: 10.3109/00365521.2012.677956. Epub 2012 May 10. Scand J Gastroenterol. 2012. PMID: 22571283
-
Biliary stenting with a prototype expandable Teflon endoprosthesis.Endoscopy. 1998 Oct;30(8):718-20. doi: 10.1055/s-2007-1001395. Endoscopy. 1998. PMID: 9865563 Clinical Trial.
-
[Biliary endoprosthesis using metallic stents in management of malignant biliary strictures].Nihon Rinsho. 1996 Nov;54(11):3143-56. Nihon Rinsho. 1996. PMID: 8950968 Review. Japanese.
-
Endoscopic retrograde cholangiopancreatography for distal malignant biliary stricture.Gastrointest Endosc Clin N Am. 2012 Jul;22(3):479-90. doi: 10.1016/j.giec.2012.04.024. Epub 2012 Jun 13. Gastrointest Endosc Clin N Am. 2012. PMID: 22748244 Review.
Cited by
-
Surgery for periampullary and pancreatic carcinoma: a Liverpool experience.Ann R Coll Surg Engl. 1997 Jul;79(4):259-63. Ann R Coll Surg Engl. 1997. PMID: 9244068 Free PMC article.
-
Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer.Ann Surg Oncol. 1996 Sep;3(5):470-5. doi: 10.1007/BF02305765. Ann Surg Oncol. 1996. PMID: 8876889
-
Cystic duct patency in malignant obstructive jaundice. An ERCP-based study relevant to the role of laparoscopic cholecystojejunostomy.Ann Surg. 1995 Mar;221(3):265-71. doi: 10.1097/00000658-199503000-00008. Ann Surg. 1995. PMID: 7536405 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical